{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    20,
    24
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Table of Contents Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.1",
        "sectionTitle": "Background and Purpose",
        "description": "Reference from Table of Contents to Background and Purpose section"
      },
      {
        "id": "ref_2",
        "name": "Inclusion Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.1",
        "sectionTitle": "Inclusion Criteria",
        "description": "Reference to subject inclusion criteria within Study Design section"
      },
      {
        "id": "ref_3",
        "name": "Exclusion Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.2",
        "sectionTitle": "Exclusion Criteria",
        "description": "Reference to subject exclusion criteria within Study Design section"
      },
      {
        "id": "ref_4",
        "name": "Deviation from Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.3",
        "sectionTitle": "Deviation from Inclusion/Exclusion Criteria",
        "description": "Reference to procedures for handling deviations from eligibility criteria"
      },
      {
        "id": "ref_5",
        "name": "SAE Definition Cross-Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "14.1.4",
        "sectionTitle": "Serious Adverse Event",
        "description": "Cross-reference to criteria 2a and 2b within SAE definition section"
      },
      {
        "id": "ref_6",
        "name": "ISO Standard Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.4",
        "sectionTitle": "Clinical Quality Assurance and Quality Control",
        "description": "Reference to ISO 14155:2020 compliance requirements"
      },
      {
        "id": "ref_7",
        "name": "CIP Amendment Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "9",
        "sectionTitle": "Amendments of the Clinical Investigation Plan",
        "description": "Reference to original protocol and amendment procedures"
      },
      {
        "id": "ref_8",
        "name": "ADE Definition Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "14.1.3",
        "sectionTitle": "Adverse Device Effect",
        "description": "Reference to instructions for use within ADE definition"
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "Error! Bookmark not defined.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table of Contents - Section 1.2 Objective",
        "pageNumber": 3
      },
      {
        "id": "annot_2",
        "text": "Error! Bookmark not defined.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table of Contents - Section 6.2.7 Number of Study Centers",
        "pageNumber": 3
      },
      {
        "id": "annot_3",
        "text": "Error! Bookmark not defined.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table of Contents - Section 8 Data Management",
        "pageNumber": 4
      },
      {
        "id": "annot_4",
        "text": "Error! Bookmark not defined.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table of Contents - Participant Compensation",
        "pageNumber": 4
      },
      {
        "id": "annot_5",
        "text": "***",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Data Management section",
        "pageNumber": 19
      },
      {
        "id": "annot_6",
        "text": "For the purposes of this study, the patient will only be monitored for any newly diagnosed skin condition (e.g., dermatitis, abrasion) at the site of the study device use throughout the duration of subjects' participation in the study.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "14.1.3 Adverse Device Effect",
        "pageNumber": 25
      },
      {
        "id": "annot_7",
        "text": "A planned hospitalization for pre-existing condition without a serious deterioration in health or to prevent life threatening illness or injury or permanent impairment to a body structure or a body function, is not considered to be a SAE.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "14.1.4 Serious Adverse Event",
        "pageNumber": 25
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "2.13",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2024-05-01",
        "description": "Clinical Investigation Plan for AION BIOSYSTEMS tempshield continuous temperature monitoring device study in Pediatric Emergency Department"
      }
    ],
    "summary": {
      "referenceCount": 8,
      "annotationCount": 7,
      "versionCount": 1
    }
  }
}